Assignee
CHEMGENES CORP
US·14 granted patents·2 pending applications·675 citations·filing 1991–2021
Top patents by PatentIndex Score
16 records- 0195US6015886AOligonucleotide phosphate estersCHEMGENES CORP·Filed 1997·Granted Jan 18, 2000·394 cites·14 claims
- 0291US7956169B1Synthesis of novel azo-dyes and their use in oligonucleotide synthesisCHEMGENES CORP·Filed 2010·Granted Jun 7, 2011·9 cites·24 claims
- 0389US5214135AN-protected-2'-O-methyl-ribonucleosides and N-protected 2'-O-methyl-3'-cyanoethyl-N-,N-diisopropyl phosphoramidite ribonucleosidesCHEMGENES CORP·Filed 1991·Granted May 25, 1993·117 cites·3 claims
- 0482US11634762B2RT-qPCR molecular detection and diagnosisCHEMGENES CORP·Filed 2020·Granted Apr 25, 2023·1 cites·26 claims
- 0580US5525719AN-protected-2'-O-methyl-and N-protected-3'-O-methyl-ribonucleosides and their phosphoramidite derivativesCHEMGENES CORP·Filed 1993·Granted Jun 11, 1996·84 cites·5 claims
- 0679US5744595APropargyl modified nucleosides and nucleotidesCHEMGENES CORP·Filed 1995·Granted Apr 28, 1998·60 cites·8 claims
- 0774US8933214B2RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-endCHEMGENES CORP·Filed 2012·Granted Jan 13, 2015·4 cites·3 claims
- 0868US7846436B2Oligonucleotides and related compoundsCHEMGENES CORP·Filed 2004·Granted Dec 7, 2010·6 cites·40 claims
- 0959US9718855B2Nucleosides and oligonucleotides for studies on reversal of cytotoxic and mutagenic damage of DNA and as diagnostics toolsCHEMGENES CORP·Filed 2014·Granted Aug 1, 2017·0 cites·1 claims
- 1057US9605261B2RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-endCHEMGENES CORP·Filed 2014·Granted Mar 28, 2017·0 cites·3 claims
- 1155US2021347645A1Macroporous Controlled Porosity Silica Gel Suitable For Oligonucleotide SynthesisCHEMGENES CORP·Filed 2021·Application pending·0 cites
- 1254US7932287B2Therapeutic compositions and usesCHEMGENES CORP·Filed 2005·Granted Apr 26, 2011·0 cites·5 claims
- 1354US2018066009A1Nucleosides and Oligonucleotides for Studies on Reversal of Cytotoxic and Mutagenic Damage of DNA and as Diagnostics ToolsCHEMGENES CORP·Filed 2017·Application pending·0 cites
- 1444US9969764B2Dithiolane functionalized nucleoside amidites and supports for stronger immobilization of bio-molecules on solid surfacesCHEMGENES CORP·Filed 2016·Granted May 15, 2018·0 cites·14 claims
- 1543US9441002B2Dithiolane based thiol modifier for labeling and stronger immobilization of bio-molecules on solid surfacesCHEMGENES CORP·Filed 2013·Granted Sep 13, 2016·0 cites·4 claims
- 1637US10167308B2Highly efficient synthesis of long RNA using reverse direction approachCHEMGENES CORP·Filed 2016·Granted Jan 1, 2019·0 cites·12 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →